NCT05916066View on ClinicalTrials.gov

Nicotinamide and Glaucoma

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 16, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Glaucoma
Interventions
DIETARY_SUPPLEMENT

Nicotinamide

Tabletts of 500mg Nicotinamide (B3-vitamin)

Trial Locations (1)

90187

Department of Clinical Science, Ophthalmology, Umeå University, Umeå

All Listed Sponsors
lead

Umeå University

OTHER

NCT05916066 - Nicotinamide and Glaucoma | Biotech Hunter | Biotech Hunter